WuXi PharmaTech will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements free of charge to its shareholders and ADS holders upon request. Requests should be directed to Ronald Aldridge, Director of Investor Relations, by email at ir@wuxiapptec.com.

SEC Filing Keyword Search (View search tips) Groupings Filter (View SEC Groupings descriptions) All FormsAnnual FilingsCurrent ReportsOtherRegistration Statements

View Section 16 Filings (3,4,5)

<< First | Previous | Next | Last >>

Filing Date Form Description Filing Group Downloads 04/17/13 20-F Registration of securities of foreign private issuers pursuant to section 12(b) or (g) Annual Filings 04/01/13 CT ORDER CT ORDER Other 02/14/13 SC 13G A statement of beneficial ownership of common stock by certain persons Other 02/14/13 SC 13G/A An amendment to the SC 13G filing Other 01/23/13 SC 13G/A An amendment to the SC 13G filing Other 01/14/13 CT ORDER CT ORDER Other 11/14/12 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 11/07/12 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 10/09/12 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports 08/14/12 6-K Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act Current Reports

<< First | Previous | Next | Last >>